Stephen Archer to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Stephen Archer has written about Xenograft Model Antitumor Assays.
Connection Strength
0.322
-
An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications. FASEB J. 2020 04; 34(4):5106-5127.
Score: 0.162
-
Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury. FASEB J. 2020 01; 34(1):1447-1464.
Score: 0.160